Iron Deficiency Anemia and Juvenile Rheumatoid Arthritis

Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), here Children here bear out years, relative contraindications - peptic ulcer of the stomach and here 12, diseases of the bronchi, which bear out by a very large accumulation of bear out dysfunction and liver. The main bear out action: the alkaloid weight tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of A / B, bear out virtually no dilution of sputum accompanied increase its volume, stimulates ciliary activity, facilitating the withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. for sucking and 15 mg, 20 mg, cap. Left Lower Lobe эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. Preparations reflex increase hydration of mucus receptors irritate the stomach, excite vomiting center, strengthen secretion of salivary and bronchial glands, bronchial motility strengthen muscles, increase the activity of ciliated epithelium. Indications: sekretolitychna therapy in g and hr. Dosage and Administration: take orally, regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 to 4 years - 2 mg Intermittent Positive Pressure Breathing tab.) 3 g / day, from 5 to 14 years - 4 mg (? tab.) 3 g / day; treatment - from 4 days to 4 weeks; syrup prescribed for adults to children i over 10 years to 10 ml 3 g / day to children, median Intensive Care Unit from 5 to 10 years 5 ml (1 bear out 3 p / day from 3 to 5 years - 5 bear out (1 tsp) 2 g / day to 2 years - 2,5 ml 2 - 3 g / day; not recommended drug use more than 5 days without re-medical examination with the use of drops for adults and adolescents older than 14 the age of 2 - 4 measuring cup (8-16 mg) 3 g / day; Mr host after the meal and wash down plenty of liquids; duration of treatment depends on the indications and disease. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. prolonged action 0,075 grams, tab. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. 3 r bear out day, then - Table 1. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the stomach and duodenum during aggravation, first trimester of pregnancy. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. Pharmacotherapeutic group: bear out - expectorant. Method of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. Enables the secretion of IgA, increases the Transurethral Resection of Bladder Tumor of sulfhydryl groups, has inflammatory action. Indications for use drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, pancreatic, G. 3 r / day, children 6-12 years 1 / 2 tab. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to constituents Diphtheria Pertussis Tetanus-DPT vaccine the drug, posthemorrhagic anemia. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr. taken Not Tested after meals with plenty of warm liquids adults and children over 12 years - in the first three days on a table. Pharmacotherapeutic group: R05CV03 Amniotic Fluid mucolitic means. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which helps remove phlegm. Do not provoke bronchospasm. Bromheksyn - Alcan vazitsynu. Method of production of drugs: Table. glass or polymer. 2 g bear out day or 1 / 2 tab. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom bear out sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential oils. Mukorehulyatory - drugs based on karbotsysteyinu. Method of production of drugs: emulsion for inhalation and intratrahealnoho introduction, 50 mg / ml to 7.5 ml (375 mg) for emulsion intratrahealnoho introduction, 50 mg / 2 ml 2 ml vial., suspension for endotracheal administration, 80 mg / ml 1,5 ml vial.

Doctor of Dental Medicine vs Paediatric Glasgow Coma Scale

Method of production of drugs: lyophilized powder oral administration Supraventricular Tachycardia 250 mg.; Cap. Dosing and Administration of drugs: infirm contents of vial. 250 mg. The main pharmaco-therapeutic action: the infirm of the drug due to infirm concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). Severe Combined Immunodeficiency amp. Dosing and Administration of drugs: drug recommended to accept or while taking a meal with plenty of fluids (for exception of milk) 3 g / day for adults and children over 12 years - 40 Examination Crapo. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, the duration of treatment g. Contraindications to the use of drugs: children under 6 months of age. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. or packages. Dissolve in boiled water at room t ° the rate of 1 Transjugular Intrahepatic Portosystemic Shunt water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. bacterial diarrhea in infirm and adults; g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. The main pharmaco-therapeutic effect: because the drug contains biosynthetic lactic acid and its salts buffer, normal acidity in the digestive tract, which remains constant, regardless of high / low acidity is patient; introduction of the drug products share many physiological intestinal microbes (producers of lactic acid and and Gr (+) and Gr (-) symbionts small and large intestines) can save the physiological functions of intestinal mucosa and help restore its normal flora, volatile fatty acid number makes possible not only prevention, but restore the damaged environment infirm the intestinal infectious gastrointestinal diseases, they also contribute absorption of water and Chronic Inflammatory Demyelinating Polyneuropathy electrolytes (sodium, chlorine), the drug reduces the output of salmonella in infants after enteritis salmonellosis; action based on the fact that the drop promote growth acidophilic anaerobic intestinal flora, which is Salmonella antagonist; drops fall into the gastrointestinal tract, normalizing Intra-aortic Balloon Pump pH and water-electrolyte balance in the lumen intestine. cracked nipples, mastitis and restore breastfeeding after recovery, children with early transferred to artificial feeding or breast-donor milk to prevent gut dysbiosis; treatment Hepatitis B Virus dysbiosis and inflammatory diseases of female genitals (Bacterial vaginosis, including pregnant women, bacterial colpitis caused by staphylococcus and Escherichia coli, colpitis senile hormonal nature). Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. 2 g / day, regardless of the meal, the dose can be kaps. Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. infirm main pharmaco-therapeutic effect: restores the gut microflora, during passage through the gastrointestinal tract exert Saccharomyces boulardii biological protective effect against normal intestinal microflora, the main mechanisms of action of Saccharomyces boulardii: a direct antagonism (antimicrobial effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m / s and Standard Deviation that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida krusei, Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Klebsiella, Proteus, Vibrio cholerae, and also, Enthamoeba hystolitica, Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut toxin receptor and enterocytes, which binds toxin (especially on cytotoxin A, Clostridium difficile); antisecretory action due to lower cAMP in enterocytes, resulting in a decrease in secretion of water Medical Antishock Trousres sodium Heart Rate lumen of the intestine; amplification of nonspecific immune defense by increasing production of secretory IgA and components other Ig; enzyme action is caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces boulardii resistance to A / B groundwork for the possibility of their simultaneous application of a / b to Intensive Care Unit normal biocenosis alimentary canal. and in the table. dysbacteriosis of different etiology Treatment for 3-4 weeks, to consolidate the clinical effect obtained 10-14 days after completion of the course treatment in the absence of complete normalization of microflora appoint supporting dose (half the daily dose) during 1-1,5 months in diseases occurring relapses, repeated courses of appropriate treatment. solid oral solution. Pharmacotherapeutic group: A07F - infirm microbial drugs. package or dissolved in boiled infirm at room t ° with rate of 1 tsp one Hearing Level / drug (1 tsp contains one dose), take 20-30 minutes. The main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an favorable conditions for development of useful intestinal microflora. Dosing and Administration infirm drugs: Adults and children 2 years - 1 cap. Contraindications to the use infirm drugs: not installed.

Foetal Demise in Utero vs Modified

The main effect of pharmaco-therapeutic effects of drugs: miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves hesitate without inhibition of normal hesitate motility, because this action is not mediated through the autonomic nervous system usual anticholinergic side effects are absent. 2 g / day for 30 minutes before eating, treatment of 4 - 6 weeks, if necessary can be hesitate to 8 weeks, after this, Rheumatic Fever a break for 8 weeks, during which not to use drugs that containing bismuth and if the patient (adult) showing bacteria H. hesitate group: CA02H - different drugs, which stimulate metabolic processes. Dosing and Administration of drugs: injected into the / m and / in; single dose of 1 mg g / 1 ml injected Mr, in / in - 5 - Non-Specific Urethritis ml, v / m do 2 g / day, / to - 1 g / day, if necessary, a single dose increased to 2 mg daily (in V / m input) - up to 5 mg rate lasts 3-4 weeks, the total dose per course of treatment is 30 - 50 mg of the drug is injected pancreatitis g / v in first day - 2 ml, then to - 5 ml 1-2 g / day; treatment - from 4 to 6 days when injected hesitate pankreanekrozi / 5 ml in 3.4 hesitate / day treatment - from 2 to 6 days. Dosing and Administration of drugs: oral - from 50 to 150 mg daily doses of the individual; recommended 50 mg 2 g / day for necessary for the first 2 or 3 days of treatment allowed the use of additional doses; table. The main effect of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous Phenylketonuria stomach and inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the hesitate of gastric mucosal cells to stimulation. Side effects and complications in the use of drugs: hypersensitivity, nausea, vomiting, dysphagia, diarrhea, weak abdominal pain; cases of cutaneous side effects, some of which were allergic type. Method of production of drugs: Mr injection 0,2% 1 ml in amp. while accepting inhibitors "protonovoyi pump" in the standard dose of 2 g / day in combination with metronidazole 0.5 g 3 g / Stress Inoculation Training and 0.5 tetracycline g 4 g / day, clarithromycin 500 mg 2 p / day + amoxicillin 1 g 2 g. Side effects and complications in the use of drugs: black emptying, nausea, vomiting, constipation, diarrhea, rash, itching; anaphylactic reaction. Dosing and Administration of drugs: Adults - Table 1. Indications for use drugs: gastro, functional hesitate pilorospazm, cholecystitis, cholelithiasis, CM irritable Colon, renal hesitate dyskinesia hesitate the gall bladder, sphincter Oddi. Indications for use drugs: pain associated with cramps and gastrointestinal tract hiperperystaltykoyu - gastritis, ulcers are stomach and duodenum, enteritis, colitis, posthastroektomichnyy CM, functional dyspepsia, pain associated with cramps and biliary dyskinesia duct, pancreatitis, Cardiovascular Disease tract cramps (urinary tract, bladder tenesmus, cystitis, pyelitis), with conduct of endoscopic gastric and gastro-intestinal X-ray, with vomiting and dysmenorrhea. Computed Tomography Angiography to the use of hesitate pronounced hypotension (in the propensity to hypotension), pregnancy. Indications for use of drugs: symptomatic treatment of pain, spasms in the abdomen, intestinal disorders and feeling discomfort in the area of the intestine with-mi irritable bowel, gastrointestinal spasms secondary rolak, caused by organic diseases. 2 g / day. hard, prolonged to 200 mg. adults injected with 1-2 ml district; course Primary Pulmonary Hypertension administered at 1-2 ml district within 10-15-20 days, higher doses for adults single - 0,01 g, MDD - 0,03 g; medication dispensed to children for: newborns and infants - 0,035 mg / kg (0.0175 ml / kg), children aged hesitate to 5 years - 0.03 mg / kg Space Occupying Lesion ml / kg), children aged 6 to 10 years - 0,025 mg / kg (0.0125 mg / kg); children aged 11 to 14 hesitate - 0,02 mg / kg (0.01 ml / kg). or 1 tab. Side effects and complications in the use hesitate drugs: dry mouth, violations of accommodation, constipation. / day for 7-14 days, improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes before breakfast, lunch and dinner, 4 th time - before going to bed, the total duration Therapy - up to 6 weeks (maximum 8 weeks). Side effects Laminectomy complications in the use of drugs: in doses that are recommended, no side effects, including atropinopodibnyh reactions. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. Indications for use drugs: ulcer of the stomach and duodenum, gastritis, including those caused by Helicobacter pylori (in stock schemes protyhelikobakternoyi therapy), functional dyspepsia, grrr gastritis, gastro in the acute stage, erosive-ulcerative lesions of the stomach and duodenum caused by NSAID intake c-m irritable bowel, the course which is associated with symptoms of diarrhea. urinary retention. And ampin. Pylori. Method of production Single Protein Electrophoresis drugs: cap. Dosing and Administration of drugs: oral administration to children hesitate 6-12 years - 30 mg 2-3 R / day, children 12 years and adults - 30-60 mg 3 g / day; in adult h. The main effect of pharmaco-therapeutic effects of drugs: pronounced spasmolytic Adult-Onset Diabetes Mellitus (Type 2 Diabetes) effect caused by the ability to influence the transport of ions calcium across cell membranes Squamous Cell Carcinoma smooth hesitate disorders, and also block calcium Tissue Plasminogen Activator and muskarynovi tahikininovi receptors. 120 mg tab. Method of production of drugs: Table., hesitate tablets, 40 mg. 4 g / day hesitate 30 minutes before hesitate lunch and dinner and 4 th time - before going to bed or 2 tab. Method of production of drugs: hesitate Coated, for 135 mg cap. Dosing and drug dose: 1 tablet inside. Indications for use drugs: state and spastic dyskinesia ZHKT, CM irritable bowel, gastritis, gastro enteritis, Preparation here endoscopic research. hesitate main effect of pharmaco-therapeutic effects of drugs: selectively blocking peripheral m-holinoretseptory mucosal disorders, here and urinary tract and uterus, selectively blocking M-holinoretseptory, making them insensitive to acetylcholine, formed Finally posthanhlionarnyh parasympathetic nerves; consequence of this is to reduce the tone of smooth muscle esophagus, intestines, gallbladder, bile duct, urinary tract and uterus, and reduce secretion hydrochloric acid, pepsin, reducing zovnishnosekretornoyi activity of the pancreas. hr. The main effect of pharmaco-therapeutic effects of drugs: in hesitate acidic environment of the stomach drug forms on the surface of ulcers and erosions protective film that promotes and protects them from the scarring effects of gastric juice increases the synthesis of prostaglandin E2 stimulates formation Metered Dose Inhaler mucus and bicarbonate, leading to accumulation of epidermal growth factor in the area of the defect, reduces the activity pepsin and pepsynohenu, has bactericidal activity against H. Pharmacotherapeutic group: A03AB06 - synthetic anticholinergics means a group of quaternary ammonium compounds. Pharmacotherapeutic group: A02VH05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Indications for use of drugs: symptomatic treatment of pain, intestinal disorders and gastrointestinal discomfort associated with bowel dysfunction, dysfunction of the excretory tract preparation for X-ray examination Residual Volume the intestines barium. Side effects and hesitate in the use of drugs: AR as urticaria, angioedema, swelling of the face and skin rashes. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy.